By continuing to use the site you agree to our Privacy & Cookies policy

Room temperature version of coagulation factor

Novo Nordisk UK has announced that NovoSeven – its recombinant activated factor VII product available for the treatment of bleeding episodes in people with haemophilia with inhibitors – is now available as a room temperature stable formulation from today onwards. This replaces the previous formulation, which required refrigeration.

Continue reading - simply register below

It only takes two minutes to do and you'll immediately have access to our news and opinion articles and you'll be able to sign up for our newsletters.

Already registered?

To check that you are registered please enter your email address below

Our records show you are already a registered user. Please sign-in with your password.

By continuing to use the site you agree to our Privacy & Cookies policy

Not registered?

Registration is free and takes just two minutes. After you register, you'll get access to our news and opinion stories and you'll be able to sign up to our newsletters.

newsletterpromo